Patent ductus arteriosus medical therapy in term and older children
Patent Ductus Arteriosus Microchapters |
Differentiating Patent Ductus Arteriosus from other Diseases |
---|
Diagnosis |
Treatment |
Medical Therapy |
Case Studies |
Patent ductus arteriosus medical therapy in term and older children On the Web |
American Roentgen Ray Society Images of Patent ductus arteriosus medical therapy in term and older children |
FDA on Patent ductus arteriosus medical therapy in term and older children |
CDC on Patent ductus arteriosus medical therapy in term and older children |
Patent ductus arteriosus medical therapy in term and older children in the news |
Blogs on Patent ductus arteriosus medical therapy in term and older children |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief:Cafer Zorkun, M.D., Ph.D. [2]; Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [[4]]
Assistant Editor-In-Chief: Kristin Feeney, B.S. [[5]]
In term infants and older patients, the ProstaglandinE2 inhibitors (indomethacin and ibuprofen)have not shown to be effective. This is so because the ductus in premature baby is different histologicaly from in older patients. As a result, pharmacologic therapy is only used routinely in preterm infants.